Simcere Pharmaceutical Group (SCR) Misses Q2 EPS by 2c

Article Stock Quotes (1) Comments (0)

Simcere Pharmaceutical Group (NYSE: SCR) reported Q2 EPS of $0.08, $0.02 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $83.2 million versus the consensus estimate of $86.83 million.

For earnings history and earnings-related data on Simcere Pharmaceutical Group (SCR) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
• AutoZone, Inc. (AZO) Tops Q3 EPS by 4c
• Monro Muffler, Inc. (MNRO) Reports In-Line Q4 EPS; Guides Q1, FY14

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?